29346-51-8

Usage

Urea derivative

A compound derived from urea a molecule that contains two nitrogen atoms bonded to carbon atoms.

Functional groups

Contains an ethyl group (C2H5) and a hydroxyethyl group (C2H4OH) attached to the nitrogen atoms of the urea molecule.

Polar substance

Possesses a dipole moment due to the presence of polar functional groups, making it more attracted to polar molecules and solvents.

Water-soluble

Easily dissolves in water due to its polar nature and the presence of hydrophilic functional groups.

Common use in cosmetics

Widely used in skincare products as a moisturizing agent.

Moisturizing properties

Enhances the skin's moisture retention by forming a protective layer and attracting water molecules.

Potential applications in drug delivery

Being studied for its possible use in pharmaceutical formulations and drug delivery systems due to its unique properties.

Hydroxyethyl group

A hydrophilic functional group (C2H4OH) that contributes to the compound's water solubility and moisturizing properties.

Upstream product

• 141-43-5 ethanolamine 
• 109-90-0 ethyl isocyanate 
• 5710-11-2 N-ethyl-N'-hydroxyurea 

Relevant academic research and scientific papers

ADENOSINE RECEPTOR BINDING COMPOUNDS

The present invention relates to pharmaceutical compounds and compositions of Formula (I) and methods of treatment using the compounds and compositions, especially for the treatment and/or prevention of a proliferation disorder, such as cancer. Compounds of Formula (I) as further described herein are shown modulators of the adenosine A2A receptor and exhibit antiproliferative activity. Accordingly, these compounds are useful to treat proliferative disorders such as cancer, and other adenosine receptor-related conditions including an inflammatory disease, renal disease, diabetes, vascular disease, lung disease, or an autoimmune disease.

FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE

Fumarate compounds, pharmaceutical compositions comprising the fumarate compounds, and methods of using fumarate compounds and pharmaceutical compositions for treating neurodegenerative, inflammatory, and autoimmune disorders including multiple sclerosis, psoriasis, irritable bowel disorder, ulcerative colitis, arthritis, chronic obstructive pulmonary disease, asthma, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis are disclosed.

FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE

Fumarate compounds, pharmaceutical compositions comprising the fumarate compounds, and methods of using fumarate compounds and pharmaceutical compositions for treating neurodegenerative, inflammatory, and autoimmune disorders including multiple sclerosis, psoriasis, irritable bowel disorder, ulcerative colitis, arthritis, chronic obstructive pulmonary disease, asthma, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis are disclosed.

ELECTROCHEMICAL ACYLATION AND ALKYLAMINOCARBONYLATION OF AMINES AND ALCOHOLS

Electrochemical acylation and ethylaminocarbonylation of amines and alcohols are performed by anodic oxydation of the hydroxamic acids and N-ethyl-N'-hydroxyurea, respectively, in acetonitrile at a glassy-carbon electrode.